A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis-Reference-Cited by-同舟云学术

A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis

Published:2005 Issue:6 Volume:42 Page:1382-1390
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Laleman Wim,Omasta Anita,Van de Casteele Marc,Zeegers Marcel,Vander Elst Ingrid,Van Landeghem Lien,Severi Tamara,van Pelt Jos,Roskams Tania,Fevery Johan,Nevens Frederik

Publisher

Wiley

Subject

Hepatology

Reference38 articles.

1. Complications of cirrhosis. I. Portal hypertension

2. 1 Pathophysiology of portal hypertension

3. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators

4. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough

5. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis;International Journal of Molecular Sciences;2024-02-06

2. The relationship between homoarginine and liver biomarkers: a combination of epidemiological and clinical studies;Scientific Reports;2023-03-30

3. Investigational drugs in early clinical development for portal hypertension;Expert Opinion on Investigational Drugs;2022-07-05

4. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling;Endocrinology;2021-03-13

5. Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury;PLOS ONE;2020-09-10